0001209191-15-023934.txt : 20150309 0001209191-15-023934.hdr.sgml : 20150309 20150309131120 ACCESSION NUMBER: 0001209191-15-023934 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150306 FILED AS OF DATE: 20150309 DATE AS OF CHANGE: 20150309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 850 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 850 CITY: HOUSTON STATE: TX ZIP: 77030 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slawin Kevin M. CENTRAL INDEX KEY: 0001626808 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 15684426 MAIL ADDRESS: STREET 1: C/O BELLICUM PHARMACEUTICALS, INC. STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800 CITY: HOUSTON STATE: TX ZIP: 77030 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-03-06 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001626808 Slawin Kevin M. C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030 1 1 0 0 Chief Technology Officer Stock Option (right to buy) 24.48 2015-03-06 4 A 0 60000 0.00 A 2025-03-05 Common Stock 60000 60000 D 25% of the shares subject to the stock option vest and become exercisable on March 6, 2016, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter. /s/ Alan Musso, Attorney-in-Fact 2015-03-06